ME-10092

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameME-10092
Drug Alias Namecardiovascular disease therapeutics (Acurepharma)cardiovascular disease therapeutics (Melacure)PR-5ME-10092
ClassificationSmall molecules
Mechanisms of ActionXanthine dehydrogenase modulatorsantioxidant
TargetsXanthine dehydrogenase
Therapy Area/IndicationsReperfusion InjuryCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMelacure Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A